Cargando…
Genetic basis for iMCD-TAFRO
TAFRO syndrome, a clinical subtype of idiopathic multicentric Castleman disease (iMCD), consists of a constellation of symptoms/signs including thrombocytopenia, anasarca, fever, reticulin fibrosis/renal dysfunction, and organomegaly. The etiology of iMCD-TAFRO and the basis for cytokine hypersecret...
Autores principales: | Yoshimi, Akihide, Trippett, Tanya M., Zhang, Nan, Chen, Xueyan, Penson, Alexander V., Arcila, Maria E., Pichardo, Janine, Baik, Jeeyeon, Sigler, Allison, Harada, Hironori, Fajgenbaum, David, Dogan, Ahmet, Abdel-Wahab, Omar, Xiao, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148173/ https://www.ncbi.nlm.nih.gov/pubmed/32051554 http://dx.doi.org/10.1038/s41388-020-1204-9 |
Ejemplares similares
-
International definition of iMCD-TAFRO: future perspectives
por: Nishimura, Yoshito, et al.
Publicado: (2022) -
Increased mTORC2 pathway activation in lymph nodes of iMCD‐TAFRO
por: Phillips, Alexis D., et al.
Publicado: (2022) -
Association between Insufficient Interleukin-6 (IL-6) Inhibition and Worsening Outcomes in COVID-19 and Idiopathic Multicentric Castleman Disease (iMCD), and a Mathematical Model to Predict Optimal Dosing to Completely Block IL-6 Activity
por: Rossi, Jean-Francois, et al.
Publicado: (2021) -
Reduced Plasmacytoid Dendritic Cell Output Is Associated With High Risk in Low-grade Myelodysplastic Syndrome
por: Chan, Alexander, et al.
Publicado: (2022) -
Defining and categorizing outcomes of Moral Case Deliberation (MCD): concept mapping with experienced MCD participants
por: de Snoo-Trimp, Janine C., et al.
Publicado: (2018)